| Format |
Cassette |
| Specimen |
Secretions |
| Box Specification |
20 or 10 Tests/Box |
| Certificate |
ISO 13485 & ISO 9001 |
| Shelf Life |
24 Months |
| Box Size |
155*150*68mm |
| Carton Size |
64*36*36.5cm |
Background
Newcastle disease is a highly contagious disease of birds caused by a para-myxo virus. Birds affected by this disease are fowls, turkeys, geese, ducks, pheasants, partridges, guinea fowl and other wild and captive birds, including ratites such ostriches, emus and rhea.
Humans aren't normally affected, but people in direct contact with infected birds may develop a very short-term eye infection, which passes without treatment.
Intended Use
Newcastle Disease Virus Antigen Rapid Test is a sandwich lateral flow immunochromatographic assay for the qualitative detection of Newcastle Disease Virus (NDV Ag) in avian secretions.
Hangzhou Testsea Biotechnology Co., LTD. is a national high-tech enterprise, is located in Hangzhou. Testsea has lots of researchers and workers who graduated from Zhejiang University and overseas. Testsea is specialized in the research, development, production and sales of raw materials for medical diagnosis and food safety testing. We have applied for 28 kinds of patents which cover medical diagnosis, food safety rapid testing, food enzymatic immunoassay and new enzyme preparation. Testsea provides perfect raw material solutions for scientific research institutions, enterprises, research institutes and other institutions globally. Testsea total business area is more than 56,000 square meters, including 2,000 square meters of GMP 100,000-level purification workshop, our company is strictly following ISO13485 and ISO9001 quality management system operation with research, production, quality control, finance, domestic sales and international sales, etc. Our products are well accepted by many users domestic and abroad. In addition, we establish a good business relationship with many domestic universities and in vitro diagnostic production enterprises, even with southeast Asia, Europe, Africa, Latin America, and other countries.
Testsea has a research and development team led by doctors and masters with professional workers and a well-equipment facility. The production capacity of recombinant antigens has reached 18g/month.
Testsea pursuit of "integrity, quality, responsibility" concept and adhere to the quality, the purpose of serving the society and constantly developing new high-quality diagnostic materials efforts.
){kind=link}
){kind=link}